CUMBRE PHARMACEUTICALS
Similar Organizations
Akela Pharmaceuticals
Akela Pharmaceuticals is a Medical company.
Angstorm Pharmaceuticals
Angstorm Pharmaceuticals is a Health Care company.
Deuteria Pharmaceuticals,Inc.
Deuteria Pharmaceuticals,Inc. is a Health Care company.
Hoechst Roussel Pharmaceuticals
Hoechst Roussel Pharmaceuticals is a Health Care company.
ICI Pharmaceuticals
ICI Pharmaceuticals is a Health Care company.
Merrell Dow Pharmaceuticals
Merrell Dow Pharmaceuticals is a Health Care company.
More informations about "Cumbre Pharmaceuticals"
Cumbre Pharmaceuticals, Inc. - Drug pipelines, Patents, Clinical …
Nov 1, 2024 Explore Cumbre Pharmaceuticals, Inc. with its drug pipeline, therapeutic area, technology platform, 15 literature, Disease Domain:Infectious Diseases, Technology …See details»
Cumbre Company Profile | Management and Employees List
Cumbre Pharmaceuticals Inc. is a clinical-stage pharmaceutical company focusing on developing anti-infective products for the treatment of serious and life-threatening bacterial infections, …See details»
Cumbre Pharmaceuticals - Products, Competitors, Financials, …
Cumbre Pharmaceuticals is a Dallas, Texas-based Healthcare company. Use the CB Insights Platform to explore Cumbre Pharmaceuticals's full profile. Cumbre Pharmaceuticals - …See details»
Cumbre Pharmaceuticals - Tech Company Profile - Gaebler.com …
Cumbre Pharmaceuticals is a research based specialty pharmaceutical company that discovers, develops and markets anti-infective products for the treatment of serious and life-threatening …See details»
Cumbre Pharmaceuticals Inc. - US Patent and Trademark Search
Jun 12, 2008 Cumbre Pharmaceuticals inc: uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and …See details»
CUMBRE PHARMACEUTICALS INC innovation strategy - GoodIP
CUMBRE PHARMACEUTICALS INC has a total of 16 patent applications. Its first patent ever was published in 2005. It filed its patents most often in United States, EPO (European Patent …See details»
Cumbre Pharmaceuticals Stock Price, Funding, Valuation, Revenue ...
See Cumbre Pharmaceuticals funding rounds, investors, investments, exits and more. Evaluate their financials based on Cumbre Pharmaceuticals's post-money valuation and revenue.See details»
CBR-2096 - Drug Targets, Indications, Patents - Synapse
CBR-2096, Initially developed by Cumbre Pharmaceuticals, Inc., Now, its global highest R&D status is Discontinued, Therapeutic Areas: Infectious Diseases. Biomedical products. Data. …See details»
Rifaquizinone - Drug Targets, Indications, Patents - Synapse
Cumbre Pharmaceuticals, Inc. TenNor Therapeutics Suzhou Ltd. Active Organization Dan Nuo Yi Yao （ Zhong Shan ） You Xian Gong Si TenNor Therapeutics Suzhou Ltd. University of Iowa …See details»
Cumbre Pharmaceuticals And Global Alliance For TB Drug
Sep 27, 2006 DALLAS & NEW YORK--(BUSINESS WIRE)--Cumbre Pharmaceuticals Inc, a Dallas-based biopharmaceutical company, and the Global Alliance for TB Drug Development …See details»
Cumbre Pharmaceuticals - Crunchbase
Cumbre Pharmaceuticals is a Health Care company. Start Free Trial . Chrome ExtensionSee details»
Cumbre Pharmaceuticals - CB Insights
Explore {Cumbre Pharmaceuticals's key management people. Discover current leadership team members including founders, CEO, other executives and board directors. Cumbre …See details»
Cumbre Pharmaceuticals and TB Alliance Announce Partnership to …
Sep 26, 2006 New TB Drugs Urgently Needed to Replace Treatments Designed in the 1960s. Dallas, Texas/ New York, September 27, 2006 -- Cumbre Pharmaceuticals Inc, a Dallas-based …See details»
Cumbre Pharmaceuticals and TB Alliance Announce Partnership to …
Sep 27, 2006 Cumbre Pharmaceuticals Inc. is a clinical-stage pharmaceutical company focused on the development and commercialization of anti-infective products for the treatment of …See details»
Research programme: antibacterials - Cumbre Pharmaceuticals
Cumbre Pharmaceuticals was a biopharmaceutical company that was investigating RNA polymerase inhibitors as potential therapies for bacterial infections. Research programme: …See details»
CBR-2198 - Drug Targets, Indications, Patents - Synapse
CBR-2198, Initially developed by Cumbre Pharmaceuticals, Inc., Now, its global highest R&D status is Discontinued, Therapeutic Areas: Digestive System Disorders. ... Originator …See details»
In Vitro Evaluation of CBR-2092, a Novel Rifamycin-Quinolone …
A .gov website belongs to an official government organization in the United States. Secure .gov websites use HTTPS A lock ... CBR-2092 and ABT-719 (A-86719.0) were synthesized at …See details»
CBR703 - Drug Targets, Indications, Patents - Synapse
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.See details»
ICI Pharmaceuticals - Crunchbase Company Profile & Funding
Organization. ICI Pharmaceuticals . Connect to CRM . Save . Summary. People. Signals & News. Similar Companies. About. ICI Pharmaceuticals is a Health Care company. Private; ...See details»